Your Research Is New. Is Your Invention Novel?

You have an exciting result.

Your experiments show that knocking down Protein X makes cancer cells much more sensitive to Drug Y.

Knockdown: experimentally reducing the expression of a gene or protein, commonly using techniques such as RNA interference.

You search PubMed.

Nobody seems to have reported it.

You search Google Scholar.

Still nothing.

So your research is new.

But is your invention novel?

Not necessarily.

Meet the prior art

Suppose your experiments suggest that inhibiting Protein X could make Drug Y a much more effective cancer treatment.

You therefore propose a fairly broad patent claim:

A method of treating cancer using an inhibitor of Protein X in combination with Drug Y.

Then the patent search finds an old document.

It describes treating cancer using Compound ABC together with Drug Y.

And Compound ABC is a known inhibitor of Protein X.

There is just one catch.

The old document says nothing about your discovery.

It doesn't say that inhibiting Protein X sensitises cancer cells to Drug Y. It doesn't contain your experiments. It doesn't explain the biological mechanism you discovered.

So surely your invention is still new?

Not necessarily.

A Singapore note: We are using a method-of-treatment claim here because it makes the novelty concept easy to see. In Singapore, methods of treatment of the human or animal body by surgery or therapy are generally excluded from patentability under section 16(2) of the Patents Act. In practice, medical inventions may instead be claimed in allowable forms, such as claims directed to substances or compositions for particular medical uses. The novelty principle we are illustrating remains the same.

Look at what your claim covers

Your claim isn't limited to your experimental result.

It broadly covers:

Protein X inhibitor + Drug Y + treating cancer

Now look at the prior art:

Compound ABC + Drug Y + treating cancer

And we already know:

Compound ABC is an inhibitor of Protein X.

That means the earlier treatment falls within the scope of your proposed claim.

Your claim covers any inhibitor of Protein X.

Compound ABC is one such inhibitor.

So even though the earlier researchers may not have understood the mechanism you discovered, they had already disclosed something that falls within your broad claim.

In patent language, the earlier disclosure may anticipate the claim.

A specific example can destroy a broad claim

This is an important feature of patent novelty.

If you claim a broad category, an earlier disclosure of something falling within that category can be enough to cause a novelty problem.

Imagine claiming:

A composition containing a metal spring.

But someone had already disclosed the same composition containing a copper spring.

Copper is a metal.

So the earlier copper spring falls within your broader claim to a metal spring.

The same logic applies to our Protein X example.

You claim:

an inhibitor of Protein X

The prior art discloses:

Compound ABC

If ABC is an inhibitor of Protein X, ABC falls within the scope of your broader term.

Importantly, this does not necessarily work in reverse.

Suppose the earlier document only disclosed a metal spring, without identifying copper.

That generic disclosure would generally not, by itself, anticipate a later claim specifically to a copper spring.

So:

Earlier copper → later metal: potentially not novel.

Earlier metal → later copper: not automatically not novel.

Whether that narrower selection is inventive is a separate question — one we will come back to.

But I discovered why it works

And that may be scientifically important.

Perhaps nobody previously realised that Compound ABC's inhibition of Protein X was responsible for sensitising the cancer cells to Drug Y.

Your experiments may reveal an entirely new biological mechanism.

That could be a significant scientific discovery.

But patent novelty asks a different question.

It does not simply ask:

Did you discover something nobody knew before?

It asks whether what you are claiming has already been disclosed.

If your claim covers something already disclosed in the prior art, discovering a new explanation for why it works does not necessarily make that claim novel.

What counts as prior art?

Prior art isn't limited to the papers you would normally find while doing a literature review.

It can include earlier patent documents and other information that was already publicly available before the relevant date.

That is why a patent search can look quite different from a PubMed search.

The question isn't simply:

“Has anyone published my biological finding?”

It is:

“Has anyone already disclosed something that falls within what I am trying to claim?”

Novelty is about the claim

This is why identifying the invention matters.

Your scientific finding might be:

Inhibiting Protein X sensitises cancer cells to Drug Y.

Your proposed patent claim might be:

Using a Protein X inhibitor with Drug Y to treat cancer.

Those aren't quite the same thing.

The first describes what you discovered.

The second defines what you are trying to obtain patent protection for.

And it is the latter that has to survive the prior art.

The takeaway

“Nobody has published my result” does not necessarily mean your claim is novel.

Your research may reveal a new mechanism or explanation.

But if the prior art already discloses something that falls within your claim, you may still have a novelty problem.

So don't just ask:

“Is my finding new?”

Also ask:

“What exactly am I claiming — and has anyone disclosed that before?”

Disclaimer: This article is for general education about patents and how scientific findings relate to patent novelty. It uses a fictional Protein X / Compound ABC / Drug Y scenario for illustration only. It is not legal advice. Patent rules vary by jurisdiction; speak to your technology-transfer office or a qualified IP professional before filing or publishing.